Evidence map›Paper›PMID 40160890›Full record

ArticleBioinformatics and biology insights2025

Development of a Novel mRNA Vaccine Against

Abdur Razzak, Otun Saha, Khandokar Fahmida Sultana, Mohammad Ruhul Amin, Abdullah Bin Zahid, Afroza Sultana, Uditi Paul Bristi, Sultana Rajia, Nikkon Sarker, Md Mizanur Rahaman and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Bioinformatics and biology insights, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Abdur RazzakDepartment of Microbiology, Noakhali Science and Technology University, Noakhali, Bangladesh.
Otun SahaDepartment of Microbiology, Noakhali Science and Technology University, Noakhali, Bangladesh.ORCID https://orcid.org/0000-0001-9159-0437
Khandokar Fahmida SultanaDepartment of Microbiology, Noakhali Science and Technology University, Noakhali, Bangladesh.
Mohammad Ruhul AminDepartment of Microbiology, Noakhali Science and Technology University, Noakhali, Bangladesh.
Abdullah Bin ZahidDepartment of Microbiology, Noakhali Science and Technology University, Noakhali, Bangladesh.
Afroza SultanaDepartment of Microbiology, Noakhali Science and Technology University, Noakhali, Bangladesh.
Uditi Paul BristiDepartment of Microbiology, Noakhali Science and Technology University, Noakhali, Bangladesh.
Sultana RajiaDepartment of Microbiology, Noakhali Science and Technology University, Noakhali, Bangladesh.
Nikkon SarkerDepartment of Microbiology, Noakhali Science and Technology University, Noakhali, Bangladesh.
Md Mizanur RahamanDepartment of Microbiology, University of Dhaka, Dhaka, Bangladesh.
Newaz Mohammed BahadurDepartment of Chemistry, Noakhali Science and Technology University, Noakhali, Bangladesh.ORCID https://orcid.org/0009-0005-7258-4636
Foysal HossenDepartment of Microbiology, Noakhali Science and Technology University, Noakhali, Bangladesh.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Shigellosis remains a major global health concern, particularly in regions with poor sanitation and limited access to clean water. This study used immunoinformatics and reverse vaccinology to design a potential mRNA vaccine targeting

Indexed as

MDSmolecular dockingmRNAmultitope vaccinereverse vaccinologyShigella species

Identifiers

PMID40160890
PMCPMC11951904

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.